Welcome to our dedicated page for SONENDO news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on SONENDO stock.
Sonendo, Inc. (SONX) is a pioneering company in the dental industry, dedicated to improving oral health through advanced technology. As a privately held, venture-backed firm, Sonendo has developed the GentleWave® System, a groundbreaking innovation in root canal therapy. This system employs multisonic ultracleaning™ technology which uses a broad spectrum of acoustic energy to clean root canals more effectively than traditional methods.
The GentleWave® System is designed to reach deep into the lateral canals and microscopic tubules of the root canal system, ensuring the removal of tissue, debris, biofilm, and bacteria. This technology provides a less invasive and more efficient alternative to standard instrumentation, aiming to save teeth and improve patient outcomes.
Sonendo's commitment to innovation is backed by extensive research and development. The company receives support from prominent investors such as CVF, LLC, Dinova Capital, Fjord Ventures, Meritech Capital Partners, NeoMed Management, and Orbimed Advisors LLC.
In addition to their flagship product, Sonendo is continuously exploring new technologies and methodologies to enhance dental care. Their work not only benefits dental practitioners by enhancing the cleaning process but also significantly impacts patients' lives by offering more effective and gentle treatment options.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Stifel 2022 Healthcare Conference on November 15 at 10:55 a.m. Eastern Time. An audio webcast will be available on their website. Sonendo focuses on innovative treatments for tooth decay via the patented GentleWave® System, offering less invasive procedures with improved clinical outcomes. The company also owns TDO Software, enhancing dental practice management.
Sonendo has received Health Canada regulatory approval for its GentleWave G4 System, aimed at improving the treatment of tooth decay in Canada. This next-generation technology enhances user experience with a simplified workflow and advanced features, including battery backup and multi-operatory connectivity. A recent clinical trial showed that 99.5% of patients reported no pain during procedures using GentleWave Technology. This approval marks a significant expansion of Sonendo’s product offerings in Canada, reinforcing its commitment to endodontic practices.
Sonendo, Inc. (NYSE: SONX) is set to release its financial results for Q3 2022 on November 9, 2022, after market close. The management will hold a conference call at 1:30 p.m. PT to discuss results. The GentleWave® System, developed by Sonendo, aims to enhance dental procedures by cleaning tooth decay without removing tooth structure, offering improved patient outcomes. The company also owns TDO® Software, which streamlines endodontic practice management.
Sonendo has launched the GentleWave G4 System, an advanced dental technology aimed at enhancing root canal treatment. The system features improved workflow, broad-spectrum acoustic energy, and advanced fluid dynamics for superior cleaning and patient outcomes. A recent clinical trial indicated that 99.5% of patients experienced minimal to no pain during the procedure. The G4 system is designed for future upgradeability and operational efficiency with features like battery backup and multi-operatory connectivity, enhancing both patient care and practice productivity.
Sonendo, Inc. (NYSE: SONX) has announced its second annual EndoCon, an endodontic conference focused on innovation, to take place in San Diego from October 20-22. The event will offer hands-on learning, lectures, and networking opportunities for clinicians and staff, featuring keynote speakers Joel Goldberg and Jessica Metcalfe. With over 400 attendees last year, EndoCon aims to enhance knowledge and skills in modern endodontics through interactive sessions and industry expert insights.
Sonendo, Inc. (NYSE: SONX) announced a private placement of common stock and pre-funded warrants, generating $63 million in gross proceeds. Key investors include Pura Vida Investments and First Light Asset Management. The financing bolsters the company’s balance sheet and supports its mission of improving patient care through innovative dental technologies. Sonendo plans to utilize the proceeds for commercialization efforts, product expansion, and general corporate purposes. The placement is expected to close on September 27, 2022.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, announced its sponsorship of the inaugural Women in Endodontics summit in Tucson, Arizona, from September 23-25. The summit features educational sessions led by notable endodontists and aims to foster networking and professional growth among women in the field. Noteworthy speakers include Dr. Srikumar S. Rao and Dr. Jessica E. Metcalfe. The initiative aligns with Sonendo's commitment to promoting leadership opportunities for women in dentistry, driving inclusivity within the industry.
Sonendo, Inc. (NYSE: SONX), a dental technology leader, will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13 at 2:55 p.m. ET. An audio webcast of the presentation will be accessible via the company’s website. Sonendo is known for its GentleWave® System, which treats tooth decay using innovative technology that preserves tooth structure while enhancing clinical outcomes.
The GentleWave System improves cleaning efficacy, healing rates, and minimizes post-operative pain, thus optimizing workflow for dental practices.
Sonendo reported a strong Q2 2022, achieving $10.5 million in total revenue, a 32% increase from the previous year. The GentleWave console revenue rose to $2.7 million, and procedure instrument revenue hit $4.8 million. Despite a slight dip in gross margin to 24% due to supply chain issues, operational efficiency is improving. The company launched the CleanFlow Technology in April 2022 and has an install base of approximately 900 units. Sonendo anticipates full-year revenue between $40.5 million and $42.5 million, indicating 22% to 28% annual growth.
FAQ
What is the current stock price of SONENDO (SONX)?
What is the market cap of SONENDO (SONX)?
What is Sonendo, Inc. known for?
What technology does the GentleWave® System use?
How does the GentleWave® System benefit patients?
Who are some of Sonendo's investors?
Is Sonendo a publicly traded company?
What is multisonic ultracleaning™ technology?
What makes the GentleWave® System unique?
How does Sonendo support dental practitioners?
What impact does Sonendo aim to have on dental care?
Where can I find the latest news about Sonendo?
